Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
Van de Walle
Johan
J
Department of Pediatric Nephrology, University Hospital Ghent, Ghent, Belgium. johan.vandewalle@ugent.be
Van Herzeele
Charlotte
C
Raes
Ann
A
D000281:Administration, Intranasal; D000284:Administration, Oral; D000368:Aged; D050034:Antidiuretic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced*; D053206:Nocturnal Enuresis / Q000188:drug therapy*; D012307:Risk Factors
D050034:Antidiuretic Agents; D003894:Deamino Arginine Vasopressin